ENTRY       D01131                      Drug
NAME        Lafutidine (JP18/INN);
            Protecadin (TN)
FORMULA     C22H29N3O4S
EXACT_MASS  431.1879
MOL_WEIGHT  431.5484
CLASS       Gastrointestinal agent
             DG01975  Agents for peptic ulcer
              DG01481  Histamine receptor H2 antagonist
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2325
            ATC code: A02BA08
            Product: D01131<JP>
EFFICACY    Anti-ulcerative, H2 receptor antagonist
TARGET      HRH2 [HSA:3274] [KO:K04150]
  PATHWAY   hsa04020(3274)  Calcium signaling pathway
            hsa04080(3274)  Neuroactive ligand-receptor interaction
            hsa04971(3274)  Gastric acid secretion
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]
INTERACTION  
STR_MAP     map07038  Antiulcer drugs
            map07227  Histamine H2/H3 receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A02 DRUGS FOR ACID RELATED DISORDERS
               A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
                A02BA H2-receptor antagonists
                 A02BA08 Lafutidine
                  D01131  Lafutidine (JP18/INN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              23  Digestive organ agents
               232  Peptic ulcer agents
                2325  H2 blockers
                 D01131  Lafutidine (JP18/INN)
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01975  Agents for peptic ulcer
               DG01481  Histamine receptor H2 antagonist
                D01131  Lafutidine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               D01131  Lafutidine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D01131  Lafutidine
            Drug classes [BR:br08332]
             Gastrointestinal agent
              DG01481  Histamine receptor H2 antagonist
               D01131  Lafutidine
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Histamine
                HRH2
                 D01131  Lafutidine (JP18/INN) &lt;JP&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D01131  Lafutidine
              D01131  Lafutidine tablets
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01131
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01131
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01131
DBLINKS     CAS: 118288-08-7
            PubChem: 7848194
            ChEBI: 31759
            LigandBox: D01131
            NIKKAJI: J485.641D
ATOM        30
            1   C1x C    11.2700  -29.7500
            2   C1x C    11.2700  -31.1500
            3   C1x C    12.4600  -31.8500
            4   N1y N    13.7200  -31.1500
            5   C1x C    13.7200  -29.7500
            6   C1x C    12.4600  -29.0500
            7   C1b C    14.9100  -31.8500
            8   C8y C    16.1000  -31.1500
            9   C8x C    17.2900  -31.8500
            10  C8y C    18.5500  -31.1500
            11  N5x N    18.5500  -29.7500
            12  C8x C    17.3600  -29.0500
            13  C8x C    16.1000  -29.7500
            14  O2a O    19.7400  -31.8500
            15  C1b C    20.9300  -31.1500
            16  C2b C    22.1200  -31.8500
            17  C2b C    23.5200  -31.8500
            18  C1b C    24.7100  -31.1500
            19  N1b N    25.9000  -31.8500
            20  C5a C    27.0900  -31.1500
            21  C1b C    28.2800  -31.8500
            22  S4a S    29.4700  -31.1500
            23  C1b C    30.6600  -31.8500
            24  C8y C    31.8500  -31.1500
            25  O3c O    29.4700  -29.7500
            26  O5a O    27.0900  -29.7500
            27  C8x C    32.2700  -29.8200
            28  O2x O    32.9700  -31.9900
            29  C8x C    34.0900  -31.1500
            30  C8x C    33.6700  -29.8200
BOND        32
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 2
            10    9  10 1
            11   10  11 2
            12   11  12 1
            13   12  13 2
            14    8  13 1
            15   10  14 1
            16   14  15 1
            17   15  16 1
            18   16  17 2
            19   18  19 1
            20   18  17 1
            21   19  20 1
            22   20  21 1
            23   21  22 1
            24   22  23 1
            25   23  24 1
            26   22  25 2
            27   20  26 2
            28   27  24 2
            29   24  28 1
            30   28  29 1
            31   29  30 2
            32   27  30 1
///
